Poland· PL-100273930
Propycil 50 mg
A propylthiouracil product containing propylthiouracilum, registered in Poland by Admeda Arzneimittel GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Propylthiouracil is registered in 14 of 19 countries.
Countries holding a registration under ATC H03BA02 (propylthiouracil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Propylthiouracil · ATC H03BA02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of propylthiouracil costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.89 in Switzerland to $1.64 in France — a ×1.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Propylthiouracil · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FR France$1.64
- CH Switzerland$0.89
The record
At a glance
URPL (Poland)- Active substance
- Propylthiouracilum
- Manufacturer
- Admeda Arzneimittel GmbH
- Country
- Poland (PL)
- ATC code
- H03BA02
- ATC class
- Propylthiouracil
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990956906
- gtin05909990956951
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for propylthiouracil.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Propylthiouracil · interactions on record
92 records
- 9 severe
- 41 moderate
- 42 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Propylthiouracil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPropylthiouracil 50mg tabletsTeva UK Ltd
- United StatesPropylthiouracilAmerican Health Packaging
- CzechiaPROPYCILAdmeda Arzneimittel GmbH, Hamburg
- CanadaHALYCILHALEWOOD CHEMICALS LIMITED
- SwitzerlandPropycil 50, TablettenCuratis AG
- NetherlandsPropylthiouracil Aurobindo 50 mg, tablettenAurobindo Pharma B.V.
- IrelandPropylthiouracil 50 mg tabletsHalewood Chemicals (Ireland) Limited
- FrancePROPYLEX 50 mg, compriméASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Prothiucil
- Belgium · Propylthiouracil Orifarm, Propylthiouracile Orifarm
- Bulgaria · Propycil
- Cyprus · Prothuril
- Czechia · Propycil
- Germany · Propycil, Thyreostat Ii
- Denmark · Propyltiouracil Medic
- France · Propylex
- United Kingdom (Northern Ireland) · Propylthiouracil Blue Bio Pharma (Uk) Limited, Propylthiouracil Halewood Chemicals
- Greece · Prothuril
- Croatia · Propiltiouracil Alkaloid
- Hungary · Propycil
- Ireland · Propylthiouracil Halewood Chemicals (Ireland)
- Luxembourg · Propylthiouracile Orifarm
- Malta · Propylthiouracil Halewood Chemicals (Ireland)
- Netherlands · Propylthiouracil Aurobindo
- Portugal · Propycil
- Slovakia · Propycil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/92a5379c-ab9b-4faa-9329-ce45d9a9d613 GET /v1/drugs/92a5379c-ab9b-4faa-9329-ce45d9a9d613?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909990956906 ¦ Rp ¦ 74452\n20 tabl.\n05909990956951 ¦ Rp ¦ 74569\n100 tabl.",
"substance": "Propylthiouracilum 50 mg",
"common_name": "Propylthiouracilum",
"pl_product_id": "100273930",
"pozwolenie_nr": "19865",
"auth_procedure": "NAR",
"authorisation_validity": "2025-09-10"
}See everything about propylthiouracil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.